DrugPatentWatch Database PreviewSee Plans and Pricing
« Back to Dashboard
Maribavir is an investigational drug.
There have been 9 clinical trials for Maribavir. The most recent clinical trial was a Phase 3 trial, which was initiated on July 1st 2007.
The most common disease conditions in clinical trials are Cytomegalovirus Infections, Infection, and Communicable Diseases. The leading clinical trial sponsors are Shire, Glaxo Wellcome, and [disabled in preview].
Recent Clinical Trials for Maribavir
|A Study Comparing the Pharmacokinetics and Palatability of Two Candidate Pediatric Powder-for-Oral-Suspension Formulations of Maribavir to the Current Maribavir Tablet Formulation Administered in Healthy Adult Participants||Shire||Phase 1|
|Study for the Treatment of Cytomegalovirus (CMV) Infection in Hematopoietic Stem Cell Transplant Recipients||Shire||Phase 3|
|Efficacy and Safety of Maribavir in Transplant Recipients With Cytomegalovirus (CMV) Infections That Are Refractory or Resistant to Treatment||Shire||Phase 3|